Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Junshi Biosciences (1877 HK)
Watchlist
220
Analysis
Health Care
•
China
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
15 Nov 2024 22:01
Voluntary Announcement - Approval By The Mhra For Marketing Of Toripalimab
Attachment
Exchange Announcement •
12 Nov 2024 21:02
Overseas Regulatory Announcement - Shanghai Junshi Biosciences Co., Ltd.* Announcement On The Completion Of The Plan For The Reduction In The Shareholding Of The Shareholders Holding More Than 5% Of The Shares And The Result Of The Plan For The Reduction
Attachment
Exchange Announcement •
29 Oct 2024 20:47
Overseas Regulatory Announcement - Shanghai Junshi Biosciences Co., Ltd.* Indicative Announcement On The Changes In Equity Of The Shareholders Holding More Than 5% Of The Shares By 1%
Attachment
Exchange Announcement •
29 Oct 2024 20:39
Overseas Regulatory Announcement - Shanghai Junshi Biosciences Co., Ltd.* Announcement On The Convening Of The 2024 Third Quarterly Results Briefing
Attachment
Exchange Announcement •
29 Oct 2024 20:28
Overseas Regulatory Announcement - Shanghai Junshi Biosciences Co., Ltd.* Announcement On Changing The Implementation Entity For Investment Projects
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.3
x